Lindsay Rocco | Elixir Health Public Relations |
Matthew Pauls | President and CEO |
Fred Cohen | Chief Medical Officer |
Brian Davis | Chief Financial Officer |
Esther Hong | Janney |
Nick Rubino | Stifel |
Hartaj Singh | Oppenheimer & Company |
Liisa Bayko | JMP Securities |
Good morning, ladies and gentlemen, and welcome to the Strongbridge Biopharma Corporate Update and Fourth Quarter 2018 Earnings Conference Call. [Operator Instructions] As a reminder, this call will be recorded. I would now like to introduce your host for today's conference, Ms. Lindsay Rocco of Elixir Health Public Relations.
You now may begin.